Literature DB >> 12188940

Major clinical and physiological benefits of early high doses of mannitol for intraparenchymal temporal lobe hemorrhages with abnormal pupillary widening: a randomized trial.

Julio Cruz1, Giulio Minoja, Kazuo Okuchi.   

Abstract

OBJECTIVE: We evaluated long-term clinical outcomes and postoperative physiological findings in acutely comatose patients with nonmissile surgical intraparenchymal temporal lobe hemorrhages and abnormal pupillary widening who received early preoperative high-dose mannitol (HDM) versus conventional dose mannitol treatment in the emergency room.
METHODS: One hundred forty-one adult patients with traumatic, nonmissile, acute, intraparenchymal temporal lobe hemorrhages associated with early abnormal pupillary widening were prospectively and randomly assigned to receive emergency preoperative intravenous HDM treatment (approximately 1.4 g/kg; 72 patients) and were compared with a control group that was treated with a lower preoperative mannitol dose (approximately 0.7 g/kg; 69 patients).
RESULTS: Early preoperative improvement of abnormal bilateral pupillary widening was significantly more frequent in the study group than in the control group (P < 0.03). The same was true for abnormal unilateral pupillary widening (P < 0.01). Early HDM treatment in the emergency room was also associated with significantly better 6-month clinical outcomes (P < 0.005). The two groups of patients were well matched with respect to diameter of the temporal lobe hemorrhages (approximately 4 cm) as well as timing of clot removal (approximately 2.5 hours after injury). Postoperative physiological findings revealed statistically significant between-group differences, with higher intracranial pressure and lower cerebral extraction of oxygen (global relative cerebral hyperperfusion) in the control group than in the HDM group. Postoperative global brain ischemia (abnormally low arteriojugular lactate difference values) was rare and was found for less than 3% of the patients in both groups.
CONCLUSION: Early preoperative HDM administration in the emergency room was associated with improved clinical outcomes for adult comatose patients with acute, nonmissile, intraparenchymal temporal lobe hemorrhages and associated abnormal pupillary widening. Early improvement of bilateral or unilateral pupillary abnormalities and better postoperative control of intracranial hypertension and associated global relative cerebral hyperperfusion seemed to be relevant factors that were related to improved outcomes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12188940

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  20 in total

1.  Doubts over head injury studies.

Authors:  Ian Roberts; Richard Smith; Stephen Evans
Journal:  BMJ       Date:  2007-02-24

Review 2.  Comparison of equimolar doses of mannitol and hypertonic saline for the treatment of elevated intracranial pressure after traumatic brain injury: a systematic review and meta-analysis.

Authors:  Min Li; Tao Chen; Shu-da Chen; Jing Cai; Ying-Hong Hu
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

3.  Osmolar therapy in pediatric traumatic brain injury.

Authors:  Tellen D Bennett; Kimberly D Statler; E Kent Korgenski; Susan L Bratton
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

Review 4.  Head injury (moderate to severe).

Authors:  Ian Maconochie; Mark Ross
Journal:  BMJ Clin Evid       Date:  2010-06-10

5.  Osmotherapy: use among neurointensivists.

Authors:  Angela N Hays; Christos Lazaridis; Ron Neyens; Joyce Nicholas; Sarah Gay; Julio A Chalela
Journal:  Neurocrit Care       Date:  2011-04       Impact factor: 3.210

6.  Treatment of acute intracerebral hemorrhage.

Authors:  Bart M Demaerschalk; Maria I Aguilar
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

Review 7.  Head injury (moderate to severe).

Authors:  Ian Maconochie; Mark Ross
Journal:  BMJ Clin Evid       Date:  2007-10-17

8.  Treatment of cerebellar masses.

Authors:  Mahmut Edip Gurol; Erik K St Louis
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

Review 9.  Mannitol for acute traumatic brain injury.

Authors:  Abel Wakai; Aileen McCabe; Ian Roberts; Gillian Schierhout
Journal:  Cochrane Database Syst Rev       Date:  2013-08-05

10.  Modern treatment options for intracerebral hemorrhage.

Authors:  William D Freeman; Thomas G Brott
Journal:  Curr Treat Options Neurol       Date:  2006-03       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.